Showcasing the best in Jap pharma
Worth about US $ 65 billion, the pharmaceutical market in Japan is considered to be number two in the world. Currently, Japan represents 13% of the global pharmaceutical business.
CPhI/ICSE 2005: A review
Gateway to Japan's vast pharmaceutical marketplace, the CPhI Japan exhibition 2005 & International Contract Services Expo (ICSE) 2005, held last year at Tokyo Big Sight Exhibition Center from 20-22 April 2005
Malladi buys US-based Novus Fine Chemicals
The Chennai-based Malladi Drugs and Pharmaceuticals, the largest Indian manufacturer of Pseudoephedrine Hcl, has acquired US-based Novus Fine Chemicals for around €19 million
India's API business goes places
A number of the fast-growing "second wave" of Indian generic companies and API manufacturers have continued to forge alliances with generics in the US
Tech solutions to drive health sector boom in India
With an estimated 1.7 lakh foreigners already flying to India for medical treatment annually, the country is poised to capture the fast-growing market for off-shore healthcare and help solve the crisis of surging medical expenses
Chugai files NDA for Tarceva in Japan
A New Drug Application has been submitted in Japan covering the use of its flagship product, Tarceva (erlotinib), for the treatment of advanced or recurrent non-small cell lung cancer (NSCLC), reported OSI Pharmaceuticals, Inc.
EC draws up new GMP guideline for excipients
Companies who manufacture excipients for use by pharmaceutical finished dose manufacturers are facing an uncertain regulatory environment as the European Commission
Excipient makers in India & China to benefit
Having already become formidable forces in the production of active pharmaceutical ingredients (APIs), India and China in particular are poised to enter the European excipients market in the next four to five years.
sanofi-aventis to retrieve all Acomplia rights in Japan
sanofi-aventis is to retrieve all rights to its anti-obesity pill Acomplia in Japan from Astellas Pharma as part of its aim to strengthen its presence in the country, the world's third largest drugmaker said here.
Centaurus Pharma plans API manufacturing facility in AP
Centaurus Pharma, is planning to set up a bulk drug unit at Village Kondapalli in Krishna District of Andhra Pradesh.
Biocon expands Jap operations
Biocon intends to increase customer base in Japanese market as the company is gearing up for expansion in the region.
API China 2006 spring edition to be held at Chengdu from 18-20 May
The spring edition of API China 2006, China's leading exhibition for the pharmaceutical manufacturing sector covering the complete spectrum of products from raw material, fine chemical, intermediate, ingredients
Micro Labs plans Japanese foray
The Karnataka pharma major Micro Labs plans to enter the Japanese market in the next three to four years.
Sven Genetech to launch peptide bulk actives
The Hyderabad-based Sven Genetech Ltd, subsidiary of Jupiter Bioscience Limited, has developed in-house process capabilities for commercial manufacture of peptide based bulk actives, which it plans to commence from 2006-07.
IT adoption gains momentum in SE Asia
The market for healthcare information technology (IT) in Southeast Asia (SEA) is growing at a fast pace because of the high economic growth of countries in the region.
Copyright © Saffron Media Pvt. Ltd.